The First Thing

Studies with preprints and journal versions are listed under the earlier preprint date. CQ, a known autophagy inhibitor that is in clinical use, can efficiently ameliorate acute lung injury and dramatically improve the survival rate in mice infected with live avian influenza A H5N1 virus. An update to this paper, including originally excluded patients, confirms the effectiveness of HCQ+AZ on viral clearance and early discharge . Recommends HCQ for prophylaxis in asymptomatic healthcare workers as found effective in-vitro and in-vivo. CQ is known in nanomedicine research for the investigation of nanoparticle uptake in cells, and may have potential for the treatment of COVID-19.

The Second Thing

There is a lack of evidence-based information about what drugs work best for patients with gastroparesis. Drugs are often prescribed off-label by doctors, based on their clinical experience and how the drugs treat similar symptoms in other conditions. Food and Drug Administration for the treatment of gastroparesis. Azithromycin hasn’t been evaluated in clinical studies of pregnant women. However, when used during pregnancy, the drug hasn’t been found to increase the risk of pregnancy loss, birth defects, or other problems. Taking this blood thinner drug with azithromycin may increase your risk of bleeding.

The Third Thing

Two things you should consider when taking any medication is the possible drug interactions and potential problems related to health conditions you have. Since the start of the pandemic, researchers have observed a marked increase in antibiotic use. A review of COVID-19 case data found that more than 70% of these patients received antimicrobial treatment despite less than 10% having bacterial or fungal coinfections – amplifying risks for antimicrobial resistance. Azithromycin and amoxicillin can be used to treat several of the same conditions. These include bronchitis, sinusitis, strep throat, pneumonia, ear infections, skin infections, and lower respiratory infections.